Showing results (61-70 of 126) with videos related to
Sort By:
Pageof 13
Frontiers in Cellular Neuroscience|January 2, 2026
Neurosteroid withdrawal disrupts GABAergic system development in human cortical organoids: implications for preterm birthHelene Lacaille, Ekaterina Lebayle, Barbara Corneo, et al.Stroke|June 4, 1999
Replicability of SF-36 summary scores by the SF-12 in stroke patientsA S Pickard, J A Johnson, A Penn, et al.Science Translational Medicine|September 10, 2010
Integration of early physiological responses predicts later illness severity in preterm infantsSuchi Saria, Anand K Rajani, Jeffrey Gould, et al.AMIA ... Annual Symposium Proceedings. AMIA Symposium|February 25, 2011
Combining Structured and Free-text Data for Automatic Coding of Patient OutcomesSuchi Saria, Gayle McElvain, Anand K Rajani, et al.Neurology|October 1, 1980
Presumably Azorean disease in a presumably non-Portuguese familyE B Healton, J C Brust, D L Kerr, et al.Fundamental and Applied Toxicology : Official Journal of the Society of Toxicology|January 1, 1995
Environmental tobacco smoke: experimental facts and societal issuesH Witschi, K E Pinkerton, C R Coggins, et al.Gynecologic Oncology|December 1, 2018
Preoperatively predicting non-home discharge after surgery for gynecologic malignancyCourtney A Penn, Neil S Kamdar, Daniel M Morgan, et al.Journal of the American Academy of Dermatology|October 1, 2014
Vulvar nevi, melanosis, and melanoma: an epidemiologic, clinical, and histopathologic reviewEra Caterina Murzaku, Lauren A Penn, Christopher S Hale, et al.Cell Death & Disease|July 21, 2023
ATAD2 is a driver and a therapeutic target in ovarian cancer that functions by upregulating CENPEPraveen Guruvaiah, Suresh Chava, Chiao-Wang Sun, et al.Gynecologic Oncology Reports|June 2, 2022
Cost-effectiveness of hyperthermic intraperitoneal chemotherapy at primary cytoreduction of epithelial ovarian cancer based on residual disease statusCourtney A Penn, Erica V Carballo, Christine S Walsh, et al.Pageof 13